Novocure
NVCR
10.71
+0.02
+0.19%
Novocure
US · NVCR
#2889 by market cap
Listed 2015
10.71
+0.02
+0.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 3 analysts
Buy
Avg price target 26.67 +149.0%
Price target rangecurrent 10.71
Low20.00
Avg26.67
High31.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-10 | Ladenburg Thalmann | -- | Buy | 31.00 |
| 2026-10-30 | Wells Fargo | -- | Hold | 15.00 |
| 2026-10-30 | Evercore | -- | Buy | 20.00 |
| 2026-10-26 | Piper Sandler | -- | Buy | 29.00 |
| 2026-07-24 | Piper Sandler | -- | Buy | 29.00 |
| 2026-07-24 | Wedbush | -- | Hold | 20.00 |
| 2026-07-24 | H.C. Wainwright | -- | Buy | 52.00 |
| 2026-07-23 | H.C. Wainwright | -- | Buy | 52.00 |
| 2026-07-13 | H.C. Wainwright | -- | Buy | 46.00 |
| 2026-07-13 | J.P. Morgan | -- | Hold | 17.00 |
| 2026-06-22 | H.C. Wainwright | -- | Buy | 46.00 |
| 2026-06-18 | H.C. Wainwright | -- | Buy | 46.00 |
| 2026-05-26 | Piper Sandler | -- | Buy | 27.00 |
| 2026-05-04 | Wells Fargo | -- | Hold | 17.00 |
| 2026-05-01 | Evercore | -- | Buy | 20.00 |
| 2026-05-01 | H.C. Wainwright | -- | Buy | 48.00 |
| 2026-04-29 | H.C. Wainwright | -- | Buy | 48.00 |
| 2026-04-20 | H.C. Wainwright | -- | Buy | 49.00 |
| 2026-04-06 | Evercore | -- | Buy | 16.00 |
| 2026-03-27 | H.C. Wainwright | -- | Buy | 49.00 |
| 2026-03-25 | Piper Sandler | -- | Buy | 27.00 |
| 2026-02-26 | H.C. Wainwright | -- | Buy | 49.00 |
| 2026-02-25 | Piper Sandler | -- | Buy | 27.00 |
| 2026-02-18 | Piper Sandler | -- | Buy | 27.00 |
| 2026-02-12 | Piper Sandler | -- | Buy | 27.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-29 | -- | ±17.67% | -7.48% (in line) |
| 2026/Q2 | 2026-07-23 | -- | ±16.10% | +28.39% (beat) |
| 2026/Q1 | 2026-04-30 | -- | ±20.64% | +27.49% (beat) |
| 2025/Q4 | 2026-02-26 | -- | ±18.71% | -8.27% (in line) |
| 2025/Q3 | 2025-10-30 | -- | ±13.07% | -4.90% (in line) |
| 2025/Q2 | 2025-07-24 | -- | ±14.05% | -24.05% (beat) |
| 2025/Q1 | 2025-04-24 | -- | ±20.51% | +4.39% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±13.22% | -12.43% (in line) |
| 2024/Q3 | 2024-10-30 | -- | ±15.83% | +0.59% (in line) |
| 2024/Q2 | 2024-07-25 | -- | ±16.14% | -0.75% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±15.97% | +11.38% (in line) |
| 2023/Q4 | 2024-02-22 | -- | ±20.69% | -2.43% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Novocure discussion 0 comments